
Science 37
AcquiredOne Site. Any Patient. Total Access
Los Angeles, United States · Founded 2014 · $148.0M raised
- Headquarters
- Los Angeles, California
- Employees
- 201–500
- Founded
- 2014
- Business Model
- B2B
- Website
- science37.com
- Total Funding
- $148.0M
- Last Round
- $40.0M Venture RoundAug 2020
- Rounds
- 5
About
Science 37 is the first and only FDA-inspected direct-to-patient clinical trial site. Decentralized clinical trial (DCT) operating model branded MetaSite allows sponsors to deliver research directly to patients' homes. Full suite including recruitment, home visits, remote monitoring, telehealth. Acquired by eMed in 2024 for ~$38M.
Summary
Science 37 is a Digital Health company based in Los Angeles, United States, founded in 2014. It has raised $148.0M in total across 5 rounds, most recently a $40.0M Venture Round round in Aug 2020. Investors include Lux Capital, Redmile Group and PPD.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2020
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Alphabet-backed biotechnology company researching biology of aging and developing interventions t...

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.
Telehealth platform providing personalized health and wellness treatments for men and women, cove...
